An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

Authors: Amy M. Avila, Ilona Bebenek, Jessica A. Bonzo, Todd Bourcier, Karen L Davis Bruno, David B. Carlson, John Dubinion, Ikram Elayan, Wafa Harrouk, Shwu‐Luan Lee, Donna L. Mendrick, Jill Merrill, Jackye Peretz, Emily Place, Muriel Saulnier, Ronald L. Wange, Jia Yao, Dong Zhao, Paul C. Brown - Regulatory Toxicology and Pharmacology 2020 cited by 183